November 19, 2009
A recent publication in the October issue of The Medical Letter may help to eliminate the fear many people have about generic drugs. A systematic review of 47 studies comparing the effectiveness of generic versus brand name drugs in the treatment of cardiovascular disease was conducted. No evidence was found that showed any superiority in the brand name drugs.
The publication also reviewed other types of drugs, such as antimicrobials, proton-pump inhibitors, levothyroxine, and antiepileptic drugs. After reviewing all of the data, The Medical Letter concluded: “The continuing claims of pharmaceutical manufacturers and others that generic drugs are inferior to brand name originals still lack convincing documentation.”
(Source) Press
